Fairmount Funds Management’s Korsana Biosciences KRSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$291M Buy
+9,103,729
New +$253M 18.27% 2

Other funds holding KRSA

Fairmount Funds Management's KRSA Position: Q3 2026 in Review

Fairmount Funds Management opened a new position in Korsana Biosciences (KRSA) in Q3 2026: 9,103,729 shares worth $291M. The stake represents 18.27% of the portfolio and ranks #2 among its holdings.

44 funds tracked by Wall St. Rank hold KRSA as of Q3 2026.

  • Fairmount Funds Management held 9,103,729 shares of Korsana Biosciences worth $291M as of Q3 2026.
  • Korsana Biosciences was a new Fairmount Funds Management position in Q3 2026.
  • Korsana Biosciences made up 18.27% of Fairmount Funds Management's portfolio in Q3 2026, its #2 holding.
  • 44 funds tracked by Wall St. Rank held Korsana Biosciences as of Q3 2026.

Based on Fairmount Funds Management's 13F filing for Q3 2026, filed 16 Nov 2026.